SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-20-000118
Filing Date
2020-11-12
Accepted
2020-11-12 16:04:38
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-20200930.htm   iXBRL 10-Q 1085871
2 EX-31.1 exhibit31120200930-ngv.htm EX-31.1 15610
3 EX-31.2 exhibit31220200930-ngv.htm EX-31.2 15374
4 EX-32.1 exhibit32120200930-ngv.htm EX-32.1 4347
5 EX-32.2 exhibit32220200930-ngv.htm EX-32.2 4335
11 dare-20200930_g1.jpg GRAPHIC 130914
  Complete submission text file 0001401914-20-000118.txt   5451680

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20200930.xsd EX-101.SCH 46222
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20200930_cal.xml EX-101.CAL 52075
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20200930_def.xml EX-101.DEF 217690
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20200930_lab.xml EX-101.LAB 522286
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20200930_pre.xml EX-101.PRE 319609
12 EXTRACTED XBRL INSTANCE DOCUMENT dare-20200930_htm.xml XML 691182
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 201306566
SIC: 2834 Pharmaceutical Preparations